Perimenopause is the transition period leading up to menopause. It typically begins in a woman’s 40s, (but can start earlier) and can last several years. During this time, hormone levels fluctuate unpredictably.
Common symptoms include:
- Irregular periods
- Heavier or lighter bleeding
- Sleep disruption
- Mood changes
- Brain fog
- Hot flashes or night sweats
- Not feeling “like yourself”
Perimenopause is a clinical diagnosis, which means in most women perimenopause is diagnosed based on symptoms and menstrual pattern changes.
Hormone levels fluctuate significantly during this transition, so a single lab test is often misleading. Testing may be helpful in certain situations, but it’s not routinely required.
This is a common source of confusion.
Combined hormonal contraceptives aka “the pill” or “oral contraceptive pills”:
- Contain higher synthetic hormone doses than standard hormone therapy
- Suppress ovulation
- Provide reliable contraception
- Can regulate bleeding
- Can improve vasomotor symptoms (e.g. hot flushes, night sweats)
Hormone therapy:
- Uses lower, physiologic estrogen and/or progesterone doses
- Does not reliably prevent ovulation
- Is intended primarily for vasomotor symptom relief
The best option depends on age, reproductive goals, and your health history.

No.
Perimenopause can begin in the early 40s and occasionally in the late 30s. Symptoms should not be dismissed solely based on age.
Sleep disturbance is one of the most common perimenopause symptoms and may occur even before hot flashes begin.
Contributors include:
- Nocturnal vasomotor symptoms
- Progesterone decline
- Increased nighttime awakenings
- Anxiety
- Changes in circadian rhythm
Sleep disruption can worsen mood symptoms, weight gain, and cognitive issues.
Yes.
Ovulation becomes unpredictable but does not stop entirely until menopause is reached (12 months without a period).
Women who wish to avoid pregnancy should use contraception until menopause is confirmed.

Menopause is defined retrospectively after 12 consecutive months without periods not due to another pathological or physiological cause. The median age of menopause in the US is 51 years.
After 12 consecutive months without a period, you are considered postmenopausal. This time represents the permanent cessation of ovarian follicular activity and results in sustained low estrogen levels, which has systemic effects on:
- Cardiovascular health
- Bone density
- Genitourinary tissues
- Metabolic function
Yes. Hormone therapy may provide additional health benefits beyond symptom control.
Evidence-supported benefits include:
- Prevention of bone loss and reduction in osteoporotic fracture risk
- Improvement in genitourinary health
- Favorable effects on sleep quality
- Possible cardiometabolic benefits when initiated early
- Reduced incidence of colon cancer
Hormone therapy is not prescribed solely for disease prevention, but these additional effects are important in shared decision-making.
Vasomotor symptoms last an average of 7–9 years, though duration varies widely. Some women experience symptoms into their 60s.
Symptom duration is individualized, and treatment decisions should reflect severity, quality-of-life impact, and preferences.

GSM refers to chronic estrogen deficiency affecting the:
- Vulva
- Vagina
- Urethra
- Bladder
Symptoms include:
- Vaginal dryness
- Painful sex
- Urinary urgency
- Recurrent urinary tract infections
Unlike vasomotor symptoms, GSM does not improve over time without intervention.
No. Hormone therapy is one option — and often the most effective for hot flashes and night sweats — but it’s not the only option.
Non-hormonal treatments include:
- Other medications (e.g., SSRIs/SNRIs), gabapentin, neurokinin-3 receptor antagonists
- Cognitive behavioral therapy
- Lifestyle strategies
Treatment should match your symptoms, preferences, and health history.
The term “bioidentical” refers to hormones structurally identical to endogenous hormones made by your body (e.g., estradiol, micronized progesterone).
Many FDA-approved therapies use bioidentical hormones and are regulated for safety and efficacy.
Custom-compounded hormones are not FDA-approved, are not standardized, and are not recommended as first-line therapy unless there is a specific medical need.